跳至主要内容
临床试验/CTRI/2019/01/017070
CTRI/2019/01/017070已完成未知

A prospective, double blind,randomized, placebo controlled Interventional study to evaluate the safety and efficacy of Enzobiotics ( Synbiotics and Proteolytic Enzymes )in pre dialysis kidney disease patients

Myline Biotech India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Subjects aged between 18 and 70yrs
  • 2 Stage 3 4 and 5
  • 3 Patients wanting to delay dialysis.
  • 4 Willing to come for regular follow up visits
  • 5 Able to give written informed consent

排除标准

  • 1 Pregnant and lactation.
  • 2 Autoimmune disease e g SLE/Vasculities
  • 3 Subjects with hepatic impairement (SGOT or SGPT levels more than 3 times the upper limit)
  • 4 Diabetic foot infection patients
  • 5 Subjects with uncontrolled cardiovascular events.
  • 6 Patients who have been prescribed Synbiotics and Enzymes.
  • 7Subjects with any other severe systemic illness and in the opinion of the investigator would be non compliant with the visit schedule or study procedures.

研究者

发起方
Myline Biotech India Pvt Ltd

相似试验